)
Shares of Cipla were up over 1.5% at Rs 640 amid reports that the company might re-start supplying anti-HIV drugs to the National Aids Control Organisation (Naco) in the next two months.
According to reports, the Mumbai-based pharma major had during the second half of last year, stopped bidding for Naco tenders.
Cipla confirmed it had participated in the Naco’s paediatric tenders, which were being evaluated. “Once the applications are checked, Naco will place orders. No orders have been placed by Naco so far. It is believed this process will take two months,” a statement from the company said.
The stock opened at Rs 629 and touched a high of Rs 645. At 11:35AM, over 670,000 shares were traded so far on both the stock exchanges.
